392 related articles for article (PubMed ID: 23302558)
1. [Multicenter, randomized, controlled clinical trial on preventing antibiotic-associated diarrhea in children with pneumonia using the live Clostridium butyricum and Bifidobacterium combined Powder].
Investigating Group for Prevention of AAD in Children with Pneumonia by Clostridium Butyricum and Bifidobacterium
Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):732-6. PubMed ID: 23302558
[TBL] [Abstract][Full Text] [Related]
2. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Goldenberg JZ; Lytvyn L; Steurich J; Parkin P; Mahant S; Johnston BC
Cochrane Database Syst Rev; 2015 Dec; (12):CD004827. PubMed ID: 26695080
[TBL] [Abstract][Full Text] [Related]
3. [A multicenter randomized controlled study of
Wan CM; Yu H; Liu G; Xu HM; Mao ZQ; Xu Y; Jin Y; Luo RP; Wang WJ; Fang F
Zhonghua Er Ke Za Zhi; 2017 May; 55(5):349-354. PubMed ID: 28482385
[No Abstract] [Full Text] [Related]
4. Probiotics for the Prevention of Pediatric Antibiotic-Associated Diarrhea.
Hayes SR; Vargas AJ
Explore (NY); 2016; 12(6):463-466. PubMed ID: 27688016
[TBL] [Abstract][Full Text] [Related]
5. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Guo Q; Goldenberg JZ; Humphrey C; El Dib R; Johnston BC
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD004827. PubMed ID: 31039287
[TBL] [Abstract][Full Text] [Related]
6. Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Johnston BC; Supina AL; Ospina M; Vohra S
Cochrane Database Syst Rev; 2007 Apr; (2):CD004827. PubMed ID: 17443557
[TBL] [Abstract][Full Text] [Related]
7. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial.
Pozzoni P; Riva A; Bellatorre AG; Amigoni M; Redaelli E; Ronchetti A; Stefani M; Tironi R; Molteni EE; Conte D; Casazza G; Colli A
Am J Gastroenterol; 2012 Jun; 107(6):922-31. PubMed ID: 22472744
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the effects of Bifidobacterium preparations for the prevention and treatment of pediatric antibiotic-associated diarrhea in China.
Xu HB; Jiang RH; Sheng HB
Complement Ther Med; 2017 Aug; 33():105-113. PubMed ID: 28735819
[TBL] [Abstract][Full Text] [Related]
9. Clostridium butyricum combined with Bifidobacterium infantis probiotic mixture restores fecal microbiota and attenuates systemic inflammation in mice with antibiotic-associated diarrhea.
Ling Z; Liu X; Cheng Y; Luo Y; Yuan L; Li L; Xiang C
Biomed Res Int; 2015; 2015():582048. PubMed ID: 25802855
[TBL] [Abstract][Full Text] [Related]
10. Randomised placebo-controlled double blind multicentric trial on efficacy and safety of Lactobacillus acidophilus LA-5 and Bifidobacterium BB-12 for prevention of antibiotic-associated diarrhoea.
Chatterjee S; Kar P; Das T; Ray S; Gangulyt S; Rajendiran C; Mitra M
J Assoc Physicians India; 2013 Oct; 61(10):708-12. PubMed ID: 24772726
[TBL] [Abstract][Full Text] [Related]
11. Prevention of antibiotic-associated diarrhea in children by Clostridium butyricum MIYAIRI.
Seki H; Shiohara M; Matsumura T; Miyagawa N; Tanaka M; Komiyama A; Kurata S
Pediatr Int; 2003 Feb; 45(1):86-90. PubMed ID: 12654076
[TBL] [Abstract][Full Text] [Related]
12. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial.
Allen SJ; Wareham K; Wang D; Bradley C; Hutchings H; Harris W; Dhar A; Brown H; Foden A; Gravenor MB; Mack D
Lancet; 2013 Oct; 382(9900):1249-57. PubMed ID: 23932219
[TBL] [Abstract][Full Text] [Related]
13. A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE).
Allen SJ; Wareham K; Wang D; Bradley C; Sewell B; Hutchings H; Harris W; Dhar A; Brown H; Foden A; Gravenor MB; Mack D; Phillips CJ
Health Technol Assess; 2013 Dec; 17(57):1-140. PubMed ID: 24309198
[TBL] [Abstract][Full Text] [Related]
14. Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis.
Kale-Pradhan PB; Jassal HK; Wilhelm SM
Pharmacotherapy; 2010 Feb; 30(2):119-26. PubMed ID: 20099986
[TBL] [Abstract][Full Text] [Related]
15. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials.
Szajewska H; Ruszczyński M; Radzikowski A
J Pediatr; 2006 Sep; 149(3):367-372. PubMed ID: 16939749
[TBL] [Abstract][Full Text] [Related]
16. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants.
Corrêa NB; Péret Filho LA; Penna FJ; Lima FM; Nicoli JR
J Clin Gastroenterol; 2005; 39(5):385-9. PubMed ID: 15815206
[TBL] [Abstract][Full Text] [Related]
17. Effect of a multispecies probiotic on reducing the incidence of antibiotic-associated diarrhoea in children: a protocol for a randomised controlled trial.
Łukasik J; Szajewska H
BMJ Open; 2018 Jun; 8(5):e021214. PubMed ID: 29866789
[TBL] [Abstract][Full Text] [Related]
18. Probiotics for prevention and treatment of diarrhea.
Guandalini S
J Clin Gastroenterol; 2011 Nov; 45 Suppl():S149-53. PubMed ID: 21992955
[TBL] [Abstract][Full Text] [Related]
19. Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study.
Ouwehand AC; DongLian C; Weijian X; Stewart M; Ni J; Stewart T; Miller LE
Vaccine; 2014 Jan; 32(4):458-63. PubMed ID: 24291194
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic-associated diarrhea: a refresher on causes and possible prevention with probiotics--continuing education article.
Varughese CA; Vakil NH; Phillips KM
J Pharm Pract; 2013 Oct; 26(5):476-82. PubMed ID: 24064436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
